European Journal of Pediatrics

, Volume 145, Issue 6, pp 485–492 | Cite as

Testing with growth hormone-releasing factor (GRF(1–29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency

  • M. B. Ranke
  • M. Gruhler
  • R. Rosskamp
  • G. Brügmann
  • A. Attanasio
  • W. F. Blum
  • J. R. Bierich
Original Investigations

Abstract

Growth hormone (GH) responses to GRF (1 μg/kg BW i.v.) were investigated. Comparison between GRF(1–40) and GRF(1–29)NH2 in 11 young adult volunteers gave identical results. One hundred and thirty-one children and adolescents (45 with idiopathic GHD) were tested with GRF (1–29)NH2. The maximal GH levels (max GH) in response to GRF during the 120 min test period were found suitable to characterize the response. In cases without GHD no correlation to age, sex and pubertal development was observed. A maximal GH level of above 10 ng/ml was found to be normal. In 3 out of 86 children without GHD (one with Turner syndrome; two with simple obesity) max GH fell short of 10 ng/ml, while 11 of 45 cases with GHD exceeded this margin. In GHD, max GH was inversely correlated with age. There was no difference in max GH between groups with or without perinatal pathology as a presumed cause of GHD. GH levels to GRF were positively correlated with maximal GH level during sleep in GHD, but not correlated with responses seen to insulin or arginine. The value of GRF testing for the confirmation of GHD is discussed in the light of other GH stimulatory tests and basal somatomedin C measurements. It is suggested that the combination of testing with GRF and the determination of a basal SmC level offers a safe and convenient way to diagnose GHD in clinically suspected cases, though in some cases further diagnostic tests may be needed.

Key words

GRF Growth hormone deficiency Somatomedin C 

Abbreviations

GH

growth hormone

GRF

growth hormone releasing factor

RIA

radioimmunoassay

SmC

somatomedin C

SDS

standard deviation score =\(\frac{{x - \bar x}}{{SD_{\bar x} }}\)

CA

chronological age

BA

bone age

GHD

growth hormone deficiency

CDGA

constitutional delay of growth and adolescence

IGHD

isolated growth hormone deficiency

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Arimura A, Culler MD (1985) Regulation of growth hormone secretion. In: Imura H (ed) The Pituitary Gland. Raven Press, New York, pp 221–259Google Scholar
  2. 2.
    Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL (1981) Somatomedin C mediates growth hormone negative feed-back by effects on both the hypothalamus and the pituitary. Science 212:1279–1281PubMedGoogle Scholar
  3. 3.
    Bierich JR (1972) On the aetiology of hypopituitary dwarfism. In: Pecile A, Müller EE (eds) Growth and Growth Hormone. Excerpta Medica, Amsterdam, pp 408–415Google Scholar
  4. 4.
    Bierich JR (1983) Minderwuchs. Monatsschr Kinderheilkd 131: 180–193PubMedGoogle Scholar
  5. 5.
    Binoux M, Seurin D, Lassarre C, Gourmelen M (1984) Preferential measurement of Insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation in serum IGF BP levels. J Clin Endocrinol Metab 59:453–462PubMedGoogle Scholar
  6. 6.
    Blum WF, Ranke MB, Bierich JR (1986) Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV. Acta Endocrinol 111:271–284PubMedGoogle Scholar
  7. 7.
    Borges JL, Gelato MC, Rogol AD, Vance ML, Loriaux DL, Rivier J, Blizzard RM, Furnaletto R, Evans WS, Kaiser DL, Merriam GR, Spiess J, Vale W, Thorner MO (1983) Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet 119–124Google Scholar
  8. 8.
    Brandt I (1979) Perzentilenkurven für die Gewichtsentwicklung. Bei Früh- und Reifgeborenen in den ersten fünf Jahren. der kinderarzt 10:713–718Google Scholar
  9. 9.
    Brandt I (1980) Perzentilenkurven für das Längenwachstum. Bei Früh- und Reifgeborenen in den ersten fünf Jahren. der kinderarzt 11:43–51Google Scholar
  10. 10.
    Chihara K, Kashio Y, Abe H, Minamitani N, Kaji H, Kita T, Fujita T (1985) Idiopathic growth hormone (GH) dificiency, and GH deficiency secondary to hypothalamic germinomas: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid. J Clin Endocrinol Metab 60:269–278PubMedGoogle Scholar
  11. 11.
    Dacou-Voutetakis C, Drakopoulou N, Maniati M (1983) Growth hormone levels during sleep in children. In: Laron Z, Butenandt O (eds) Evaluation of growth hormone secretion. Karger, Basel, pp 45–52Google Scholar
  12. 12.
    Daughaday WH, Maritz IK, Blethen SL (1980) Inhibition of access of bound somatomedin to membrane receptor and immuno-binding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 51:781–788PubMedGoogle Scholar
  13. 13.
    Dean HJ, Kellett JG, Bala RM, Guyda HJ, Bhaumick B, Posner BI, Friesen HG (1982) The effect of growth hormone treatment on the somatomedin levels in growth hormone-deficient children. J Clin Endocrinol Metab 55:1167–1173PubMedCrossRefGoogle Scholar
  14. 14.
    Finkelstein JW, Roffwarg HP, Boyar RM, Kream J, Hellman L (1972) Age-related changes in the twenty-four hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 35:665–670PubMedGoogle Scholar
  15. 15.
    Furnaletto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ (1977) Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60:648–657CrossRefGoogle Scholar
  16. 16.
    Frasier SA (1974) A review of growth hormone stimulation tests in children. Pediatrics 53:929–934PubMedGoogle Scholar
  17. 17.
    Grossman A, Lytras N, Savage MO, Wass JAH, Coy DH, Rees LH, Jones AE, Besser GM (1984) Growth hormone releasing factor. Comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy. Br Med J 288:1785–1787Google Scholar
  18. 18.
    Grossman A, Savage MO, Lytras N, Preece MA, Sueiras-Diaz J, Coy DH, Rees LH, Besser GM (1984) Responses to analogues of growth hormone releasing hormone in normal subjects, and in growth hormone deficient children and young adults. Clin Endocrinol 21:321–330Google Scholar
  19. 19.
    Grossman A, Savage MO, Blacklay A, Ross RM, Plowman PN, Preece MA, Coy DH, Besser GM (1985) The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature. Horm Res 22:52–57PubMedGoogle Scholar
  20. 20.
    Gelato MC, Pescovitz OH, Cassorla F, Loriaux DL, Merriam GR (1984) Dose-response relationship for the effects of growth-hormone-releasing factor-(1–44)-NH2 in young adult men and women. J Clin Endocrinol Metab 59:197–201PubMedGoogle Scholar
  21. 21.
    Greulich WW, Pyle SI (1962) Radiographic atlas of skeletal development of hand and wrist, 2nd edn. Stanford University Press, CalifGoogle Scholar
  22. 22.
    Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB (1982) Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science 218:585–587PubMedGoogle Scholar
  23. 23.
    Kaplanowitz PB, D'Ercole AJ, Van Wyk JJ, Underwood LE (1982) Plasma somatomedin-C during the first year of life. J Pediatr 100:932–934CrossRefGoogle Scholar
  24. 24.
    Losa M, Schipohl J, Müller OA, von Werder K (1984) Stimulation of growth hormone secretion with human growth hormone releasing factors (GRF 1–44, GRF 1–40, GRF 1–29) in normal subjects. Klin Wochenschr 62:1140–1143PubMedCrossRefGoogle Scholar
  25. 25.
    Moore DC, Ravulcaba RHA, Smith EK, Kelley VC (1982) Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents. Horm Res 16:49–55PubMedGoogle Scholar
  26. 26.
    Penny R, Blizzard RM (1972) The possible influence of puberty on the release of hGH in three males with isolated hGH deficiency. J Clin Endocrinol Metab 34:82–84PubMedGoogle Scholar
  27. 27.
    Ranke MB, Weber J, Bierich JR (1979) Long-term response to human growth hormone in 36 children with idiopathic growth hormone deficiency. Eur J Pediatr 132:221–238PubMedCrossRefGoogle Scholar
  28. 28.
    Reiter EO, Lovinger RD (1981) The use of a commercially available somatomedin-C radioimmunoassay in patients with disorders of growth. J Pediatr 99:720–724PubMedCrossRefGoogle Scholar
  29. 29.
    Rivier J, Spiess J, Thorner MO, Vale W (1982) Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300:276–278PubMedCrossRefGoogle Scholar
  30. 30.
    Rogol AD, Blizzard RM, Johanson AJ, Furnaletto RW, Evans WS, Rivier J, Vale WW, Thorner MO (1984) Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone 1–40 in children with short stature. J Clin Endocrinol Metab 59:580–585PubMedGoogle Scholar
  31. 31.
    Rosenthal SM, Schriock EA, Kaplan SL, Guillemin R, Grumbach MM (1983) Synthetic human pancreas growth hormone-releasing factor (hp GRF 1–44 NH2) stimulates growth hormone secretion in normal men. J Clin Endocrinol Metab 57:677–679PubMedGoogle Scholar
  32. 32.
    Schriock EA, Lustig RH, Rosenthal SM, Kaplan SL, Grumbach MM (1984) Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency. J Clin Endocrinol Metab 58: 1043–1049PubMedGoogle Scholar
  33. 33.
    Shibasaki T, Shizume K, Nakahara M, Masuda A, Jibiki K, Demura H, Wakabajashi I, Ling N (1984) Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. J Clin Endocrinol Metab 58:212–214PubMedGoogle Scholar
  34. 34.
    Takano K, Hizuka N, Shizume K, Asakawa K, Miyokawa M, Herose N, Shibasaki T, Ling NC (1984) Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism. J Clin Endocrinol Metab 58:236PubMedCrossRefGoogle Scholar
  35. 35.
    Takano K, Hizuka N, Shizume K, Honda N, Ling NC (1985) Plasma growth hormone (GH) response to single and repetitive subcutaneous administration of GH releasing factor (HpGRF-44) in normal and GH deficient children. Acta Endocrinol 108:11–19PubMedGoogle Scholar
  36. 36.
    Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children 1965. Arch Dis Child 41:454–471, 613–635PubMedCrossRefGoogle Scholar
  37. 37.
    Thorner MO, Reschke J, Chitwood J, Rogol AD, Furnaletto R, Rivier J, Vale W, Blizzard RM (1985) Acceleration of growth in two children treated with human growth hormone-releasing factor. N Engl J Med 3:4–9CrossRefGoogle Scholar
  38. 38.
    Trygstad O (1977) Transitory hGH deficiency successfully treated with hGH. Acta Endocrinol 84:11–22PubMedGoogle Scholar
  39. 39.
    Van Vliet G, Bosson D, Robyn C, Craen M, Malvaux P, Vander-schueren-Lodewyckx M, Wolter R (1985) Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children. Horm Res 22:32–45PubMedGoogle Scholar
  40. 40.
    Van Vliet G, Bosson D, Rummens E, Robyn C, Wolter R (1985) Effect of growth hormone releasing factor (GRF) on plasma growth hormone (GH) and prolactin (PRL) levels in obese children. Pediatr Res: 604 (Abstr 3)Google Scholar
  41. 41.
    Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA (1984) Impaired growth hormone response to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 311:1403–1407PubMedCrossRefGoogle Scholar
  42. 42.
    Wood SM, Chung JLC, Adams EF, Webster JD, Joplin GF, Mashiter K, Bloom SR (1983) Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF(1–44)) in acromegaly and hypopituitarism. Br Med J 286:1687–1691CrossRefGoogle Scholar
  43. 43.
    Youlton R, Kaplan SL, Grumbach MM (1969) Growth and growth hormone. IV: Limitations of the growth hormone response to insulin and arginine and of the immunoreactive insulin response to arginine in the assessment of growth hormone deficiency in children. Pediatrics 43:989–1004PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • M. B. Ranke
    • 1
  • M. Gruhler
    • 1
  • R. Rosskamp
    • 2
  • G. Brügmann
    • 1
  • A. Attanasio
    • 1
  • W. F. Blum
    • 1
  • J. R. Bierich
    • 1
  1. 1.Children's HospitalUniversity of TübingenTübingenFederal Republic of Germany
  2. 2.Children's HospitalUniversity of BonnBonnFederal Republic of Germany

Personalised recommendations